scholarly journals The Continuing Evolution of Insulin-like Growth Factor Signaling

F1000Research ◽  
2020 ◽  
Vol 9 ◽  
pp. 205 ◽  
Author(s):  
Steven A Rosenzweig

The insulin-like growth factors (IGFs; IGF1/IGF2), known for their regulation of cell and organismal growth and development, are evolutionarily conserved ligands with equivalent peptides present in flies (D. melanogaster), worms (C. elegans) among others. Two receptor tyrosine kinases, the IGF1 receptor and the insulin receptor mediate the actions of these ligands with a family of IGF binding proteins serving as selective inhibitors of IGF1/2. This treatise reviews recent findings on IGF signaling in cancer biology and central nervous system function. This includes overexpression of IGF1 receptors in enhancing tumorigenesis, acquired resistance and contributions to metastasis in multiple cancer types. There is accumulating evidence that insulin resistance, a hallmark of type 2 diabetes, occurs in the central nervous system, independent of systemic insulin resistance and characterized by reduced insulin and IGF1 receptor signaling, and may contribute to dementias including Alzheimer’s Disease and cognitive impairment. Controversy over the role(s) of IGF signaling in cancer and whether its inhibition would be of benefit, still persist and extend to IGF1’s role in longevity and central nervous system function.

2007 ◽  
Vol 4 (2) ◽  
pp. 115-123 ◽  
Author(s):  
Allen R. Nissenson ◽  
James T. Marsh ◽  
Warren S. Brown ◽  
Deane L. Wolcott

1993 ◽  
Vol 14 (7) ◽  
pp. 885-890 ◽  
Author(s):  
J. ZEITLHOFER ◽  
S. ASENBAUM ◽  
C. SPISS ◽  
A. WIMMER ◽  
N. MAYR ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document